Application 022411
- Type
- NDA
- Sponsor
- ANGELINI PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OLEPTRO | TRAZODONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | OLEPTRO | TRAZODONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022411-001 | OLEPTRO | TRAZODONE HYDROCHLORIDE | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | |
| N022411-002 | OLEPTRO | TRAZODONE HYDROCHLORIDE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 |
| N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | |
| N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | |
| N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022411-001 | OLEPTRO | 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022411-002 | OLEPTRO | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 2010-02-02 | 3a93d1ddd44b… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022411-001 | 7829120 | 2027-03-27 | U-796 | Drug product | 2010-12-06 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022411-001 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2012-03-16 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022411-002 | 7829120 | 2027-03-27 | U-796 | Drug product | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022411-002 | 8133893 | 2029-03-13 | Drug substance, Drug product | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | fa7afa93-b98c-4dc7-bbb8-ab6a058427b9 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | TRUPHARMA LLC | a57da4f8-151d-4a74-8710-6158d1da3852 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | 3b2e61b0-414c-48ae-9e13-06470c302c67 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 596c3f00-1504-eaed-e063-6294a90a08bb | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | American Health Packaging | f715085a-be56-497e-ad92-9fec3aba70b5 | 2026-08-14 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | 1f74b23d-f2eb-4c18-a583-d608b7713694 | 2026-08-10 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | dc1f347e-1acb-4c06-b36e-f15fecb7ac93 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | acd077db-e2b8-4d29-94c0-128439050c66 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | NuCare Pharmceuticals,Inc. | 81a5b557-06f6-2470-e053-2991aa0a64fd | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | a31d59ed-5949-4f85-8b73-3bfd7f72d5b8 | 2026-08-05 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | 7bba99e5-4096-4fcb-8591-dc4a9bfe975e | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Golden State Medical Supply, Inc. | 51012256-b249-ccbb-e063-6394a90af4fa | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | REMEDYREPACK INC. | 2863317d-657b-4dc6-81fb-b7158ea03498 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | A-S Medication Solutions | 007f38e0-653b-43e4-a1c1-b59997b2762a | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Bryant Ranch Prepack | 68bcae4b-f4c3-4d28-af76-d182b707fc73 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Oxford Pharmaceuticals, LLC | 283c8236-9776-44cb-b7b2-1024689de736 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Granules Pharmaceuticals Inc. | 5bc5f266-6c0e-4b9a-b6e0-ea694928b948 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Unit Dose Solutions, Inc. | 562fa890-0a39-9361-e063-6294a90a1bb5 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | Unit Dose Solutions, Inc. | 562fdfb9-c060-63bc-e063-6294a90ad840 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
| Trazodone Hydrochloride | TRAZODONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 04c287ca-5efa-469d-ab39-ff16d9b1e0b3 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | TRAZODONE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.